[1] 蔡慧云, 于波, 白雪, 左富义, 崔伟, 常家函, Cai Hui-yun, Yu Bo, Bai Xue, Zuo Fu-yi, Cui Wei, Chang Jia-han. CD44在结直肠癌病灶及转移淋巴结中的表达及临床意义 [J]. 临床军医杂志 2012.doi:10.3969/j.issn.1671-3826.2012.04.035 [2] Lee, JL, Wang, MJ, Sudhir, PR, Chen, GD, Chi, CW, Chen, JY. Osteopontin promotes integrin activation through outside-in and inside-out mechanisms: OPN-CD44V interaction enhances survival in gastrointestinal cancer cells. [J]. Cancer research 2007, 5(5). [3] Geiger TR, Peeper DS. Metastasis mechanisms. [J]. Biochimica et biophysica acta. Reviews on cancer 2009, 2(2). [4] Tuck AB, Chambers AF. The role of osteopontin in breast cancer: clinical and experimental studies. [J]. Journal of mammary gland biology and neoplasia 2001, 4(4). [5] LOUDERBOUGH J M, BROWN J A, NAGLE R B. CD44 promotes epithelial mammary gland development and exhibits altered localization during cancer progression [J]. Genes Cancer 2011, 2(08). [6] Sun, B.-S., Li, Y., Zhang, Z.-F., You, J., Wang, C.-L.. Osteopontin combined with CD44v6, a novel prognostic biomarker in non-small cell lung cancer undergoing curative resection [J]. The Annals of Thoracic Surgery: Official Journal of the Society of Thoracic Surgeons and the Southern Thoracic Surgical Association 2013, 6(6). |